单药治疗-话题@MedSci

#单药治疗#

130篇内容 | 3021人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687719, encodeId=8127168e71910, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=BMJ：COPD：三联治疗PK双药或单药治疗, objectType=article, longId=154644, objectId=082b1546442a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=082b1546442a, replyNumber=0, likeNumber=90, createdTime=2019-02-24, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=082b1546442a, moduleTitle=BMJ：COPD：三联治疗PK双药或单药治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=082b1546442a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687718, encodeId=b0ff168e71861, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Diabetes Care：2型糖尿病患者单药治疗失败后强化治疗宜早不宜迟, objectType=article, longId=154612, objectId=d84a154612a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d84a154612a1, replyNumber=0, likeNumber=73, createdTime=2019-04-17, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d84a154612a1, moduleTitle=Diabetes Care：2型糖尿病患者单药治疗失败后强化治疗宜早不宜迟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d84a154612a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687723, encodeId=ca79168e7234f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Stroke：阿司匹林联合氯吡格雷与阿司匹林单药治疗急性小中风或短暂性脑缺血发作的疗效比较, objectType=article, longId=157976, objectId=30dc15e97651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30dc15e97651, replyNumber=0, likeNumber=61, createdTime=2019-06-11, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30dc15e97651, moduleTitle=Stroke：阿司匹林联合氯吡格雷与阿司匹林单药治疗急性小中风或短暂性脑缺血发作的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30dc15e97651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687712, encodeId=0477168e712c2, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=CLIN CANCER RES：Utomilumab单药治疗晚期肿瘤, objectType=article, longId=136483, objectId=07721364831c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07721364831c, replyNumber=0, likeNumber=108, createdTime=2018-05-05, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07721364831c, moduleTitle=CLIN CANCER RES：Utomilumab单药治疗晚期肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07721364831c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687711, encodeId=e0da168e71155, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=CLIN CANCER RES：Vanucizumab单药治疗晚期实体肿瘤, objectType=article, longId=135500, objectId=5866135500ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5866135500ab, replyNumber=0, likeNumber=73, createdTime=2018-08-02, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5866135500ab, moduleTitle=CLIN CANCER RES：Vanucizumab单药治疗晚期实体肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5866135500ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687716, encodeId=478e168e71697, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=CLIN CANCER RES：Venetoclax单药治疗慢性淋巴细胞性白血病安全性分析, objectType=article, longId=149134, objectId=972614913424, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=972614913424, replyNumber=0, likeNumber=100, createdTime=2019-02-07, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=972614913424, moduleTitle=CLIN CANCER RES：Venetoclax单药治疗慢性淋巴细胞性白血病安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=972614913424)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687722, encodeId=64e6168e7225a, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Inflam Bowel Dis：硫代嘌呤代谢物监测对小儿IBD患者硫嘌呤单药治疗耐久性的影响, objectType=article, longId=157179, objectId=ac0415e179cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0415e179cd, replyNumber=0, likeNumber=60, createdTime=2019-03-16, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0415e179cd, moduleTitle=Inflam Bowel Dis：硫代嘌呤代谢物监测对小儿IBD患者硫嘌呤单药治疗耐久性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac0415e179cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687708, encodeId=011d168e708fd, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=JCEM：米托坦单药治疗晚期肾上腺皮质癌效果如何？, objectType=article, longId=130311, objectId=8bb71303112d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bb71303112d, replyNumber=0, likeNumber=116, createdTime=2018-04-11, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bb71303112d, moduleTitle=JCEM：米托坦单药治疗晚期肾上腺皮质癌效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bb71303112d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687713, encodeId=9289168e71335, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！, objectType=article, longId=137617, objectId=231413e617e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231413e617e4, replyNumber=0, likeNumber=66, createdTime=2019-02-03, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231413e617e4, moduleTitle=Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=231413e617e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687714, encodeId=be23168e714b7, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：Quizartinib单药治疗复发性/难治性FLT3-ITD突变型急性髓系白血病的效果和安全性, objectType=article, longId=140256, objectId=0af5140256d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0af5140256d5, replyNumber=0, likeNumber=56, createdTime=2018-10-20, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0af5140256d5, moduleTitle=Blood：Quizartinib单药治疗复发性/难治性FLT3-ITD突变型急性髓系白血病的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0af5140256d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687707, encodeId=8dfc168e707d9, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：依鲁替尼单药治疗慢性淋巴细胞白血病患者，随访5年的结果, objectType=article, longId=129111, objectId=a59e129111bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a59e129111bf, replyNumber=0, likeNumber=71, createdTime=2019-01-08, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a59e129111bf, moduleTitle=Blood：依鲁替尼单药治疗慢性淋巴细胞白血病患者，随访5年的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a59e129111bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687704, encodeId=03e6168e704de, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=SPARK研究（MCL 2001）：伊布替尼单药治疗硼替佐米治疗后进展的套细胞淋巴瘤患者：一项多中心Ⅱ期研究, objectType=article, longId=116537, objectId=dd4711653e32, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd4711653e32, replyNumber=0, likeNumber=57, createdTime=2018-05-22, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd4711653e32, moduleTitle=SPARK研究（MCL 2001）：伊布替尼单药治疗硼替佐米治疗后进展的套细胞淋巴瘤患者：一项多中心Ⅱ期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd4711653e32)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687710, encodeId=6fba168e7100c, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=初治和复发/难治性慢性淋巴细胞白血病使用伊布替尼单药治疗的5年经验, objectType=article, longId=133936, objectId=36181339363b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36181339363b, replyNumber=0, likeNumber=63, createdTime=2018-11-12, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36181339363b, moduleTitle=初治和复发/难治性慢性淋巴细胞白血病使用伊布替尼单药治疗的5年经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36181339363b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687709, encodeId=b9d3168e70957, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Ann Rheum Dis： Sirukumab单药与阿达木单抗单药治疗活动性类风湿性关节炎的疗效和安全性比较（SIRROUND-H）, objectType=article, longId=131097, objectId=815813109e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=815813109e4e, replyNumber=0, likeNumber=67, createdTime=2019-02-13, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=815813109e4e, moduleTitle=Ann Rheum Dis： Sirukumab单药与阿达木单抗单药治疗活动性类风湿性关节炎的疗效和安全性比较（SIRROUND-H）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=815813109e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687701, encodeId=b03d168e701f2, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤, objectType=article, longId=111593, objectId=0e981115938d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e981115938d, replyNumber=0, likeNumber=60, createdTime=2018-01-13, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e981115938d, moduleTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e981115938d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687702, encodeId=6b07168e702d7, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=伊布替尼单药治疗硼替佐米治疗后进展的套细胞淋巴瘤患者：一项多中心Ⅱ期研究(SPARK研究, MCL 2001）, objectType=article, longId=113567, objectId=c69011356e79, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c69011356e79, replyNumber=0, likeNumber=50, createdTime=2017-10-09, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c69011356e79, moduleTitle=伊布替尼单药治疗硼替佐米治疗后进展的套细胞淋巴瘤患者：一项多中心Ⅱ期研究(SPARK研究, MCL 2001）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c69011356e79)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687706, encodeId=7ebd168e70632, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=CFDA批准上市Giotrif®（阿法替尼），单药治疗EGFR敏感突变的晚期非小细胞肺癌, objectType=article, longId=121901, objectId=1fe812190145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe812190145, replyNumber=0, likeNumber=60, createdTime=2018-03-29, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe812190145, moduleTitle=CFDA批准上市Giotrif®（阿法替尼），单药治疗EGFR敏感突变的晚期非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe812190145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687705, encodeId=1f9e168e70597, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=伊布替尼单药治疗初治及rrCLL患者：5年随访结果, objectType=article, longId=116554, objectId=586f11655412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=586f11655412, replyNumber=0, likeNumber=73, createdTime=2018-09-13, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=586f11655412, moduleTitle=伊布替尼单药治疗初治及rrCLL患者：5年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=586f11655412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687703, encodeId=ad3b168e70304, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Hepatology：多重耐药乙肝患者：替诺福韦单药治疗可行吗？, objectType=article, longId=115879, objectId=992f1158e9e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=992f1158e9e6, replyNumber=0, likeNumber=63, createdTime=2018-04-15, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=992f1158e9e6, moduleTitle=Hepatology：多重耐药乙肝患者：替诺福韦单药治疗可行吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=992f1158e9e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687699, encodeId=f377168e6998c, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Leuk Lymphoma：地西他滨单药治疗复发性/难治性AML 疗效几何？, objectType=article, longId=105796, objectId=9a0d105e965e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0d105e965e, replyNumber=0, likeNumber=81, createdTime=2018-05-26, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0d105e965e, moduleTitle=Leuk Lymphoma：地西他滨单药治疗复发性/难治性AML 疗效几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a0d105e965e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

单药治疗

2020-05-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

BMJ：COPD：三联治疗PK双药或单药治疗

2019-02-24

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Diabetes Care：2型糖尿病患者单药治疗失败后强化治疗宜早不宜迟

2019-04-17

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Stroke：阿司匹林联合氯吡格雷与阿司匹林单药治疗急性小中风或短暂性脑缺血发作的疗效比较

2019-06-11

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

CLIN CANCER RES：Utomilumab单药治疗晚期肿瘤

2018-05-05

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

CLIN CANCER RES：Vanucizumab单药治疗晚期实体肿瘤

2018-08-02

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

CLIN CANCER RES：Venetoclax单药治疗慢性淋巴细胞性白血病安全性分析

2019-02-07

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Inflam Bowel Dis：硫代嘌呤代谢物监测对小儿IBD患者硫嘌呤单药治疗耐久性的影响

2019-03-16

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

JCEM：米托坦单药治疗晚期肾上腺皮质癌效果如何？

2018-04-11

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！

2019-02-03

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：Quizartinib单药治疗复发性/难治性FLT3-ITD突变型急性髓系白血病的效果和安全性

2018-10-20

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Blood：依鲁替尼单药治疗慢性淋巴细胞白血病患者，随访5年的结果

2019-01-08

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

SPARK研究（MCL 2001）：伊布替尼单药治疗硼替佐米治疗后进展的套细胞淋巴瘤患者：一项多中心Ⅱ期研究

2018-05-22

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

初治和复发/难治性慢性淋巴细胞白血病使用伊布替尼单药治疗的5年经验

2018-11-12

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Ann Rheum Dis： Sirukumab单药与阿达木单抗单药治疗活动性类风湿性关节炎的疗效和安全性比较（SIRROUND-H）

2019-02-13

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤

2018-01-13

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

伊布替尼单药治疗硼替佐米治疗后进展的套细胞淋巴瘤患者：一项多中心Ⅱ期研究(SPARK研究, MCL 2001）

2017-10-09

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

CFDA批准上市Giotrif®（阿法替尼），单药治疗EGFR敏感突变的晚期非小细胞肺癌

2018-03-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

伊布替尼单药治疗初治及rrCLL患者：5年随访结果

2018-09-13

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Hepatology：多重耐药乙肝患者：替诺福韦单药治疗可行吗？

2018-04-15

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Leuk Lymphoma：地西他滨单药治疗复发性/难治性AML 疗效几何？

2018-05-26

科室
- - 订阅+
  - 更多科室
工具
服务